Cell migration is central to evoke a potent immune response. Dendritic cell (DC) migration to lymph nodes is dependent on the interaction of C-type lectin-like receptor 2 (CLEC-2) expressed by DCs, with podoplanin expressed by lymph node stromal cells (LNSCs). However, the underlying molecular mechanisms by which CLEC-2 influences DC migration remain elusive. Here, we show that CLEC-2-dependent DC migration is tightly controlled by tetraspanin CD37, a membrane-organizing protein. Our findings demonstrate a specific molecular interaction between CLEC-2 and CD37. Myeloid cells lacking CD37 (Cd37-/-) expressed less CLEC-2 on their surface compared to wild-type cells, indicating that CD37 is required to stabilize membrane expression of CLEC-2. In addition, CLEC-2-expressing DCs lacking CD37 showed impaired adhesion, migration velocity and displacement on LNSCs. Moreover, Cd37-/-DCs failed to form actin protrusions in a 3D collagen matrix upon podoplanin-induced CLEC-2 stimulation, phenocopying CLEC-2deficient DCs (CD11c ΔCLEC-2 ). Microcontact printing experiments revealed that CD37 is required for CLEC-2 recruitment in the membrane to its ligand podoplanin. This study demonstrates that tetraspanin CD37 controls CLEC-2 membrane organization and provides new molecular insights underlying CLEC-2dependent DC migration.
Introduction
Cell migration is a key process in the initiation of immune responses (Worbs et al., 2017) . Upon encountering a foreign antigen, dendritic cells (DCs) migrate to secondary lymphoid organs (i.e. lymph nodes, spleen) to present antigen on major histocompatibility complex (MHC) and activate T and B lymphocytes. En route, DCs move along podoplanin-expressing lymph node stromal cells (LNSCs), such as lymphatic endothelial cells (LECs) and fibroblastic reticular cells (FRCs) . The interaction between C-type lectin-like receptor 2 (CLEC-2) on DCs with podoplanin on LNSCs is essential for optimal DC migration to and within the lymph node (Acton et al., 2012) . Despite the important role of CLEC-2 in DC migration, the molecular mechanisms underlying CLEC-2-dependent cell migration remain to be elucidated.
CLEC-2 (encoded by the gene Clec1b) is expressed on platelets (Suzuki-Inoue et al., 2006) and myeloid immune cells, such as DCs, macrophages and neutrophils (Colonna et al., 2000; Mourão-Sá et al., 2011; Lowe et al., 2015) . CLEC-2 plays a key role in fetal development of the lymphatic vasculature, as demonstrated by Clec1b-knockout mice which are embryonically lethal (Suzuki-Inoue et al., 2010; Bertozzi et al., 2010) . Besides podoplanin, the snake venom toxin rhodocytin is another ligand for CLEC-2. Both ligands initiate downstream signaling via Syk resulting in cell activation (Suzuki-Inoue et al., 2006; Fuller et al., 2007; Hughes et al., 2010) . Intracellular Syk-binding requires dimerization of CLEC-2 receptors, since each CLEC-2 receptor contains only a single tyrosine phosphorylation (YXXL) motif. This makes CLEC-2 a hemITAM (hemi-Immunoreceptor Tyrosine-based Activation Motif) C-type lectin receptor (CLR), similar to its homologous family member Dectin-1 (CLEC7A) that recognizes β-glucans in fungal cell walls (Brown and Gordon, 2001; Fuller et al., 2007) .
The organization of receptors in the plasma membrane of DCs plays a pivotal role in immune cell function (Zuidscherwoude et al., 2014 (Zuidscherwoude et al., , 2017b . For proper ligand binding and initiation of signaling, CLRs are dependent on localization into membrane microdomains, such as lipid rafts and tetraspanin-enriched microdomains (TEMs) (Figdor and van Spriel, 2009; Zuidscherwoude et al., 2014) . TEMs, also referred to as the tetraspanin web, are formed by the interaction of tetraspanins, a family of four-transmembrane proteins, with each other and partner proteins (Hemler, 2005; Levy and Shoham, 2005; Charrin et al., 2009; Zuidscherwoude et al., 2015; Zimmerman et al., 2016) . As such, TEMs have been implicated in fundamental cell biological functions, including proliferation, adhesion and signaling (Hemler, 2005; Levy and Shoham, 2005; Charrin et al., 2009) . Earlier work indicated that CLEC-2 clustering and signaling in blood platelets is dependent on lipid rafts Manne et al., 2015) . CLEC-2 was shown to be present as single molecules or homodimers on resting platelets, and larger clusters were formed upon rhodocytin stimulation (Hughes et al., 2010; Pollitt et al., 2014) , but the molecular mechanism underlying ligand-induced CLEC-2 clustering is yet unknown. More is known about the organization of Dectin-1, a CLEC-2 homologous family member, on immune cells. Dectin-1 molecules need to be reorganized into a "phagocytic cup" to bind and phagocytose particulate, and not soluble, β-glucan (Goodridge et al., 2011) .
Furthermore, Dectin-1 has been proposed to be present in lipid rafts (Xu et al., 2009; De Turris et al., 2015) or tetraspanin (CD63, CD37) microdomains (Mantegazza et al., 2004; Meyer-Wentrup et al., 2007; Yan et al., 2014) on myeloid cells.
Tetraspanin CD37 is exclusively expressed on immune cells with highest expression on B lymphocytes and DCs (de Winde et al., 2015) . The importance of CD37 in the immune system has been demonstrated in CD37-deficient mice (Cd37-/-) that have defective humoral and cellular immune responses (van Spriel et al., , 2012 . Interestingly, DCs that lack CD37 showed impaired spreading, adhesion and migration, leading to defective initiation of the cellular immune response (Gartlan et al., 2013; Jones et al., 2016) . Since CLEC-2 plays an important role in DC migration (Acton et al., 2012) , and its homologous receptor Dectin-1 has been shown to interact with tetraspanin CD37 (Meyer-Wentrup et al., 2007) , we hypothesized that CD37 may influence CLEC-2 membrane organization and thereby controls DC migration. In this study, we show that CLEC-2 interacts with CD37. Moreover, CLEC-2-dependent actin protrusion formation by DCs and recruitment of CLEC-2 to podoplanin is dependent on CD37 expression.
These results provide evidence that tetraspanin CD37 is required for CLEC-2 recruitment in the plasma membrane in response to podoplanin, and as such plays an important role in CLEC-2-dependent DC migration.
Results

CLEC-2 interacts with tetraspanin CD37
To investigate whether CLEC-2 interacts with tetraspanins, we performed co-immunoprecipitation experiments with HEK-293T cells transfected with human CLEC-2-MYC with or without a range of FLAGtagged human tetraspanin constructs. These experiments revealed that CLEC-2 interacts with CD37, but not with four other tetraspanins used as controls (CD9, CD63, CD151 or CD81) under conditions using 1% digitonin ( Figure 1A-B ). Interactions preserved in 1% digitonin are associated with primary (direct) interactions between a tetraspanin and its partner proteins (Serru et al., 1999) . The strength of the interaction between CD37 and CLEC-2 was comparable with two well-established primary interactions between tetraspanins and their partner proteins: CD9 with CD9P1 (Charrin et al., 2001) and Tspan14 with ADAM10 (Dornier et al., 2012; Haining et al., 2012) ( Figure 1C -D). Thus, these experiments show that CLEC-2 specifically interacts with tetraspanin CD37.
CD37-deficient myeloid cells show decreased CLEC-2 surface expression and increased CLEC-2-dependent
IL-6 production
We investigated CLEC-2 membrane expression on immune cells of Cd37-/mice. Naïve Cd37-/myeloid cells expressed significantly lower CLEC-2 levels compared to Cd37+/+ (WT) splenocytes ( Figure 2A ). It was reported that CLEC-2 expression was increased on myeloid cells upon in vivo LPS stimulation (Mourão-Sá et al., 2011; Lowe et al., 2015) . Therefore, we analyzed CLEC-2 expression on different immune cell subsets from spleens of Cd37-/and WT mice that were stimulated with LPS in vivo. CLEC-2 membrane expression was substantially increased by LPS, but this increase was significantly lower on LPS-stimulated Cd37-/myeloid cells (DCs, macrophages, granulocytes), compared to WT myeloid cells ( Figure 2B -C). This was in contrast to LPS-stimulated WT and Cd37-/lymphoid cells (B cells, T cells and NK cells) that expressed comparable CLEC-2 levels ( Figure 2C ). As a control, we investigated CLEC-2 expression on mouse platelets, which do not express CD37 (Zeiler et al., 2014) , and observed similar CLEC-2 expression on platelets of WT and Cd37-/mice ( Supplementary Figure 1 ).
Next, we investigated whether decreased CLEC-2 expression on Cd37-/immune cells had functional consequences by analyzing cytokine production. Cd37-/splenocytes produced significantly more interleukin-6 (IL-6) compared to WT splenocytes upon stimulation with the CLEC-2 ligand rhodocytin ( Figure 2D ). This was not due to a general defect of the Cd37-/immune cells since stimulating these cells with PMA/ionomycin resulted in equivalent IL-6 production compared to WT cells ( Figure 2D ). Thus, presence of CD37 is important for regulation of CLEC-2 membrane expression on myeloid cells and CD37 inhibits CLEC-2-dependent cytokine production.
CD37 controls DC migration and protrusion formation in response to podoplanin
To investigate whether CD37 was required for the migratory capacity of CLEC-2-expressing (CLEC-2 + ) DCs, we performed static adhesion and migration assays of WT and Cd37-/-CLEC-2 + (LPS-stimulated) DCs on LECs ( Figure 3A ). Adhesion of both WT and Cd37-/-CLEC-2 + DCs to inflamed (TNFα-stimulated) LECs was stable for the duration of the experiment. Interestingly, the percentage of Cd37-/-DCs adhering to the inflamed LECs was reduced when compared to WT DCs ( Figure 3B ). Moreover, migration velocity and mean square displacement of DCs were significantly decreased in absence of CD37 ( Figure 3C To investigate whether cell morphological changes underlying DC migration are CLEC-2dependent, we analyzed the ability of DCs to form protrusions in response to the CLEC-2 ligand podoplanin in a 3D collagen matrix. In response to podoplanin, the protrusion length and morphology index of WT DCs was significantly increased compared to unstimulated cells, as previously described (Acton et al., 2012) ( Figure 4A ,C-D and Supplementary Figure 2 ). DCs lacking CD37 were capable of forming short actin protrusions ( Figure 4A -B, Supplementary Figure 2 ). However, Cd37-/-DCs, despite expressing similar levels of CLEC-2 (data not shown), were unable to increase protrusion length and morphology index in response to podoplanin, instead phenocopying the defect seen in DCs lacking CLEC-2 (CD11c ΔCLEC-2 ; (Acton et al., 2012 (Acton et al., , 2014 ) ( Figure 4A ,C-D). Together, these results demonstrate that CD37-deficiency, similar to CLEC-2-deficiency, results in aberrant DC adhesion and migration on LNSCs, and decreased actin protrusion formation in response to the CLEC-2 ligand podoplanin.
CLEC-2 recruitment to podoplanin is dependent on CD37
To gain insight into the underlying mechanism by which CD37 controls CLEC-2 response to podoplanin, we analyzed local CLEC-2 recruitment to podoplanin in the presence or absence of CD37 by microcontact printing experiments. Microcontact printing (''stamping'') technology (Van Den Dries et al., 2012; Zuidscherwoude et al., 2017a) enables imaging and analysis of CLEC-2 protein recruitment in the membrane of cells towards recombinant podoplanin protein that is stamped as circular spots (5µm) on glass coverslips. Myeloid cells (RAW264.7 macrophages) were transiently transfected with murine CLEC-2 tagged to GFP (GFP-mCLEC-2) with or without murine CD37 tagged to mCherry (mCD37-mCherry) ( Figure   5A and Supplementary Figure 3A) , and incubated on coverslips with podoplanin stamps to locally engage CLEC-2 molecules at sites of podoplanin. We determined CLEC-2 membrane expression in the transfected cells to control for differences in transfection efficiency. CLEC-2 membrane expression was comparable between cells transfected with or without mCD37-mCherry ( Figure 5B ). Cells expressing both GFP-mCLEC-2 and mCD37-mCherry showed a >2-fold higher percentage of cells with local (on-stamp) CLEC-2 enrichment at sites of podoplanin, compared to cells only expressing GFP-mCLEC-2 ( Figure 5C -D, Supplementary Figure 3B ). These data indicate that CD37 significantly enhances CLEC-2 recruitment to podoplanin.
Discussion
It is well-established that CLEC-2 interaction with podoplanin is essential for DC migration and initiation of the cellular immune response (Acton et al., 2012 (Acton et al., , 2014 Astarita et al., 2015) , still the molecular mechanisms underlying this remain elusive. We identified a novel molecular interaction between CLEC-2 and CD37, which was specific for CD37 as other tetraspanins (CD9, CD63, CD81 and CD151) did not interact with CLEC-2. We discovered that DCs lacking CD37 have decreased CLEC-2 expression at the cell surface, and impaired adhesion, migration velocity and displacement on podoplanin-expressing lymph node stromal cells. Moreover, podoplanin-induced formation of actin protrusions and recruitment of CLEC-2 to podoplanin was impaired in Cd37-/-DCs.
For efficient ligand binding and activation of downstream signaling, CLRs have been postulated to depend on spatiotemporal localization into specific microdomains on the plasma membrane (Cambi et al., 2004; Meyer-Wentrup et al., 2007; Figdor and van Spriel, 2009 ). CLEC-2 has found to be present in clusters on blood platelets (Hughes et al., 2010; Pollitt et al., 2014) and CLEC-2 clusters were reported to be localized in lipid rafts Manne et al., 2015) by using detergent-resistant membrane extraction. However, this technique also enriches for tetraspanin microdomains (Claas et al., 2001; Tarrant et al., 2003; Blank et al., 2007) . We now identified a specific molecular interaction between CLEC-2 and tetraspanin CD37 indicating that CD37 microdomains form the scaffold for CLEC-2 clusters on the plasma membrane of DCs. The finding that CLEC-2 did not interact with other tetraspanins may be explained by recent super-resolution studies of the tetraspanin web in which individual tetraspanins were found in separate nanoclusters (100-120nm) at the cell surface of B cells and DCs .
Our data are in line with the demonstration that expression and stabilization of the CLEC-2 homologous family member Dectin-1 at the plasma membrane of macrophages was dependent on CD37 (Meyer-Wentrup et al., 2007) . The role of CD37 in stabilizing CLRs on the plasma membrane may also underlie our finding that CLEC-2 surface expression is decreased on Cd37-/splenocytes compared to WT splenocytes, indicating that CLEC-2 turnover is increased in absence of CD37.
Our results show that CLEC-2 + Cd37-/-DCs have an impaired capacity to adhere to podoplaninexpressing LECs, and demonstrate lower migration velocity and displacement. This is in accordance with studies showing impaired migration of Cd37-/-DCs in vivo (Gartlan et al., 2013; Jones et al., 2016) . In DC biology, tetraspanin interactions with adhesion receptors or MHC molecules are particularly important for antigen presentation and T cell activation (Sheng et al., 2009; Gartlan et al., 2010; Jones et al., 2016; Rocha-Perugini et al., 2017) . Now, we demonstrate a specific role for CD37 in controlling CLEC-2 function in migration of DCs. Cd37-/-DCs show impaired actin protrusion formation upon podoplanin stimulation, which is highly similar to the phenotype of CD11c ΔCLEC-2 DCs. Rearrangements of the actin cytoskeleton and subsequent cell movement are controlled by Rho GTPases, including RhoA and Rac1. RhoA increases actomyosin contractility via its interaction with Rho kinases (Parri and Chiarugi, 2010) , whereas Rac1 supports actin polymerization, spreading of lamellipodia and formation of membrane ruffles (Olson and Sahai, 2009; Nobes and Hall, 1995) . Since activity of Rho GTPases has been shown to change upon CLEC-2 activation by podoplanin or rhodocytin (i.e. downregulation of RhoA and upregulation of Rac1) (Acton et al., 2012) , we postulate that the underlying molecular mechanism of the defective cell migration of Cd37-/-DCs is due to deregulation of intracellular Rho GTPases as a consequence of impaired recruitment of CLEC-2 to its ligand podoplanin. This is supported by a recent study demonstrating impaired activation of Rac-1 in toxin-activated adherent Cd37-/bone marrow-derived DCs (Jones et al., 2016) . Altogether, these data support a model in which CD37 is important for CLEC-2 recruitment in the plasma membrane of myeloid cells upon podoplanin binding, which results in Syk activation and changes in Rho GTPase activity (e.g. increased Rac1 and decreased RhoA activation) leading to cell migration ( Figure 5E ).
Besides activation of Rho GTPases, CLRs can initiate intracellular Syk-dependent signaling cascades that induce cytokine production (Mócsai et al., 2010) . We found that Cd37-/myeloid cells produce higher IL-6 levels compared to WT cells upon stimulation with the CLEC-2 ligand rhodocytin, which is in line with previous reports showing production of pro-inflammatory cytokines (i.e. IL-6 and TNFα) by neutrophils and RAW macrophages upon stimulation with rhodocytin (Kerrigan et al., 2009; Chang et al., 2010) . Increased IL-6 expression upon CLR stimulation has also been shown in Cd37-/macrophages upon stimulation with the Dectin-1 ligand curdlan (Meyer-Wentrup et al., 2007) . Additionally, IL-10 production by RAW macrophages and BMDCs co-stimulated with LPS and anti-CLEC-2 Fab fragments could be reversed by Syk inhibition (Mourão-Sá et al., 2011) . Our results suggest that CD37 directly controls Syk signaling downstream of hemITAM CLRs and as such inhibits cytokine production, probably by stimulating phosphatase activity (Carmo and Wright, 1995; Chattopadhyay et al., 2003; Wright et al., 2004) . Syk activation has been reported to be negatively regulated by SH2 domain-containing protein tyrosine phosphatase 1 (SHP1) (Zhang et al., 2000; Mócsai et al., 2010) . SHP1 and CD37 have been shown to associate via the N-terminal ITIM-like domain of CD37 in chronic lymphocytic leukemia cells, which induced tumor cell death via negative regulation of AKT-mediated pro-apoptotic signaling (Lapalombella et al., 2012) . The binding of cytoplasmic signaling proteins, like protein kinase C (PKC) (Zhang et al., 2001; Zuidscherwoude et al., 2017a) , Rac1 (Tejera et al., 2013) , and suppressor of cytokine signaling 3 (SOCS3) (de Winde et al., 2016) have been reported for different tetraspanins (also reviewed in (van Deventer et al., 2017) ).
In conclusion, our results demonstrate that CD37 is required for ligand-induced CLEC-2 responses via a direct molecular interaction leading to immune cell activation and DC migration. Furthermore, this study supports a general mechanism of tetraspanin-mediated membrane organization and movement of CLRs in the plasma membrane, which underlies cytoskeletal changes and cell migration.
Materials and methods
Mice
Cd37-/mice (male, average age of three months) were generated by homologous recombination (Knobeloch et al., 2000) and fully backcrossed to the C57BL/6J background . Cd37+/+ (WT) littermates were matched for age and gender. Cd37+/+ and Cd37-/mice were bred in the Central Animal Laboratory of Radboud University Medical Center. CD11c ΔCLEC-2 mice (C57BL/6J background), selectively lacking CLEC-2 in CD11c+ cells, were generated by crossing Cd11c-cre and Clec1bfl/fl mice as previously described (Acton et al., 2014) . All murine studies complied with European legislation (directive 2010/63/EU of the European Commission) and were approved by local authorities (CCD, The Hague, the Netherlands, and Institutional Animal Ethics Committee Review Board, Cancer
Research UK and the UK Home Office, United Kingdom) for the care and use of animals with related codes of practice. All mice were housed in top-filter cages and fed a standard diet with freely available water and food.
Isolation of whole blood
Mice were anesthetized with isoflurane and whole blood was harvested via retro-orbital punction and collected in a tube containing acid-citrate-dextrose mixture (ACD; 25g/L sodium citrate, 20g/L glucose (both from Sigma-Aldrich, Zwijndrecht, The Netherlands) and 15g/L citric acid (Merck, Amsterdam, The Netherlands) to prevent clotting.
Cell culture
Bone marrow-derived DCs (BMDCs) were generated by culturing total murine bone marrow cells in complete medium (RPMI 1640 medium (Gibco, via Thermo Fisher Scientific, Bleiswijk, The Netherlands), 10% fetal calf serum (FCS; Greiner Bio-One, Alphen a/d Rijn, The Netherlands), 1% UltraGlutamine-I (UG;
Lonza, Breda, The Netherlands), 1% antibiotic-antimycotic (AA; Gibco, via Thermo Fisher Scientific, Bleiswijk, The Netherlands) and 50µM β-mercapto-ethanol (Sigma-Aldrich, Zwijndrecht, The Netherlands), containing 20ng/mL murine granulocyte-macrophage colony stimulating factor (mGM-CSF; Peprotech, via Bio-Connect, Huissen, The Netherlands), as adapted from previously described protocols (Lutz et al., 1999) .
On day 6, BMDCs were additionally stimulated with 10ng/mL LPS (Sigma-Aldrich, Zwijndrecht, The Netherlands) for 24h, unless stated otherwise.
Primary human dermal lymphatic endothelial cells (LEC) were purchased from PromoCell and cultured in manufacturer's recommended medium (Endothelial Cell Growth Medium MV2, PromoCell, Heidelberg, Germany) supplemented with 35µg/mL gentamicin (Gibco, via Fisher Scientific -UK Ltd, Loughborough, UK). As previously described (Ahmed et al., 2011) , LECs were dissociated using a 2:1 ratio of trypsin (2.5mg/ml) to EDTA (0.02%) (both from Sigma-Aldrich, Paisley, UK) and seeded on 12-well tissue culture plates coated with 2% gelatin (Sigma-Aldrich, Paisley, UK). Seeding density was chosen to yield a confluent LEC monolayer within 24h. TNF-alpha (TNFα; 100U/ml; R&D Systems, via Bio-Techne Ltd, Abingdon, UK) was added to confluent LEC monolayers for 24h before analyzing static adhesion and migration of DCs (Podgrabinska et al., 2009; Maddaluno et al., 2009; Johnson and Jackson, 2013) . Netherlands)). RAW macrophages (5x10 5 cells/transfection) were transfected with 0.5µg mCD37-mCherry and/or 0.5µg pAcGFP-mCLEC-2 as previously described (Pollitt et al., 2014) using FuGENE HD according to manufacturer's instructions (Promega, Leiden, The Netherlands).
Human (h)CLEC-2-MYC construct with C-terminal MYC tags (Fuller et al., 2007) was generated in the pEF6 expression vector (Invitrogen, via Thermo Fisher Scientific, Loughborough, UK). The FLAG-human CD37 and other human tetraspanin constructs were produced using the pEF6 expression vector with an N-terminal FLAG tag as described previously (Protty et al., 2009 ). HEK-293T cells were transiently transfected with hCLEC-2-MYC and FLAG epitope-tagged human tetraspanin expression constructs using polyethylenimine (Sigma-Aldrich, Paisley, UK) as described previously (Ehrhardt et al., 2006; Noy et al., 2015) . 
Static adhesion and migration assay
Adhesion was assessed by direct microscopic observation as previously described (Butler et al., 2005) . LEC in 12-well plates were washed three times with Medium 199 supplemented with 0.15% BSA Fraction V 7.5% (M199BSA, both from Gibco, via Thermo Fisher Scientific, Loughborough, UK) to remove residual cytokines. BMDCs (1x10 6 ) were added on top of the LEC monolayer and incubated for 10 min at 37°C, 5% CO 2 . Non-adherent cells were removed from the LECs by gentle washing three times with M199BSA medium. Imaging was performed using an Olympus Invert X70 microscope enclosed at 37°C. Digital recordings of five fields of view of the LEC surface were made using phase-contrast microscopy immediately and 10 min after washing away non-adherent cells. In between, time-lapse imaging (1 image every 10 sec) was performed for 5 min of one field of view to assess cell migration at 37°C. Digitized recordings were analyzed off-line using Image-Pro software (version 6.2, DataCell, Finchampstead, UK).
The numbers of adherent cells were counted in the video fields, averaged, converted to cells per mm 2 using the calibrated microscope field dimensions, and multiplied by the known surface area of the well to calculate the total number of adherent cells. This number was divided by the known total number of cells added to obtain the percentage of the cells that had adhered. Cell tracks of live cells were analyzed using the Manual Tracking plugin in Fiji/ImageJ software. Migration velocity was calculated as the length of each cell path/time (µm/min), and the xy trajectories were converted into mean square displacement (MSD, in µm 2 ) as previously described (van Rijn et al., 2016) .
3D protrusion assay
BMDCs (0.3x10 6 ) were seeded into a 3D collagen (type I, rat tail)/matrigel matrix (both from Corning, via Thermo Fisher Scientific, Loughborough, UK) supplemented with 10% minimum essential medium alpha medium (MEMalpha, Invitrogen, via Thermo Fisher Scientific, Loughborough, UK) and 10% FCS (Greiner Bio-One, Stonehouse, UK) on glass-bottomed cell culture plates (MatTek Corporation, Bratislava, Slovakia).
For CLEC-2 activation, 20µg/mL recombinant podoplanin-Fc (rPDPN-Fc; Sino Biological Inc., Beijing, China) (Acton et al., 2012) was added to the gel as all components were mixed. Gels were incubated overnight at 37°C, 5% CO 2 . The next day, cultures were fixed with 4% paraformaldehyde (PFA; Merck, Nottingham, UK) for 3h at RT, followed by blocking and permeabilization with 3% BSA (Roche, West Sussex, UK), 1% normal mouse serum (NMS) and 0.3% Triton X-100 in 0.1M Tris (all from Sigma-Aldrich, Paisley, UK) for 2h at RT before staining. F-actin and cell nuclei were visualized using TRITC-phalloidin and DAPI, respectively (1:1000 dilution, both from Invitrogen, via Thermo Fisher Scientific, Loughborough, UK). Cells were imaged on a Leica SP5 confocal microscope, and analyzed using Fiji/ImageJ software. Z stacks of 120µm (10µm/step) were projected with ImageJ Z Project (maximum projection), and number and length of protrusions were measured. Cell morphology (= perimeter2/4πarea) was calculated using the area and perimeter of cells by manually drawing around the cell shape using F-actin staining.
Microcontact printing
PDMS (poly(dimethylsiloxane)) stamps with a regular pattern of 5µm circular spots were prepared as previously described (Van Den Dries et al., 2012) . Stamps were incubated with 200µg/mL rPDPN-Fc (Sino Biological Inc., Beijing, China) for CLEC-2 stimulation, and 10μg/mL donkey anti-rabbit IgG (H&L)-Alexa647 (Invitrogen, via Thermo Fisher Scientific, Loughborough, UK) to visualize the spots, diluted in PBS (Braun, Aschaffenburg, Germany) for 1 hour at RT. Stamps were washed with demineralized water and dried under a nitrogen stream. The stamp was applied to a cleaned glass coverslip for 1 min and subsequently removed. Transfected RAW macrophages were seeded on the stamped area and incubated for 12 min at 37˚C. Cells were fixed with 4% PFA (Merck, Darmstadt, Germany) for 20 min at RT. Samples were washed with PBS (Braun, Aschaffenburg, Germany) and demineralized water (MilliQ; Merck Millipore, Amsterdam,
The Netherlands) and embedded in Mowiol (Sigma-Aldrich, Zwijndrecht, The Netherlands). Imaging was performed on an epi-fluorescence Leica DMI6000 microscope, and plot profiles were created using Fiji/ImageJ software. For the population of cells in contact with rPDPN-Fc spots, we determined the percentage showing on-stamp enrichment of mCLEC-2-GFP by independent visual analysis with support of Fiji/ImageJ software.
Statistics
Statistical differences between two groups (e.g. WT and Cd37-/cells) regarding IL-6 production, adhesion, CLEC-2 enrichment and NFAT-luciferase activity were determined using (un)paired Student's t-test or nonparametric Mann-Whitney test (in case of non-Gaussian distribution). Statistical differences between three groups (e.g. WT, Cd37-/and CD11c ΔCLEC-2 cells) or two or more parameters (e.g. genotype and time)
were determined using two-way ANOVA with Sidak's or Tukey's multiple comparisons test. Statistical tests were performed using GraphPad Prism software, and all differences were considered to be statistically significant at p≤0.05. 
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